Instil Bio
31 hedge funds and large institutions have $45.9M invested in Instil Bio in 2024 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 13 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
3% more funds holding
Funds holding: 30 → 31 (+1)
69% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 13
Holders
31
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$3.77M | |
| 2 | +$253K | |
| 3 | +$137K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$35.9K |
| 5 |
Barclays
London,
United Kingdom
|
+$5K |
Top Sellers
| 1 | -$198K | |
| 2 | -$139K | |
| 3 | -$132K | |
| 4 |
Squarepoint
New York
|
-$113K |
| 5 |
Two Sigma Advisers
New York
|
-$78.8K |